Performance of the new BioMonitor 2‐AF insertable cardiac monitoring system: Can better be worse? P Lacour, PL Dang, M Huemer, AS Parwani, P Attanasio, B Pieske, ... Pacing and Clinical Electrophysiology 40 (5), 516-526, 2017 | 35 | 2017 |
The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE‐CRT Study P Lacour, PL Dang, DA Morris, AS Parwani, W Doehner, F Schuessler, ... ESC Heart Failure 7 (3), 1072-1084, 2020 | 20 | 2020 |
Magnetic field–induced interactions between phones containing magnets and cardiovascular implantable electronic devices: Flip it to be safe? P Lacour, PL Dang, FR Heinzel, AS Parwani, F Bähr, A Kucher, ... Heart rhythm 19 (3), 372-380, 2022 | 13 | 2022 |
Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis? F Blaschke, P Lacour, PL Dang, AS Parwani, F Hohendanner, T Walter, ... ESC Heart Failure 8 (4), 2591-2596, 2021 | 5 | 2021 |
What physicians do in case of a failure of the pace-sense part of a defibrillation lead P Lacour, A Parwani, M Huemer, P Attanasio, PL Dang, J Luebcke, ... Herz 45 (4), 362-368, 2020 | 2 | 2020 |
Left ventricular global longitudinal strain is a long-term predictor of pacemaker-associated cardiomyopathy C Plappert, P Lacour, A Parwani, LH Boldt, F Baehr, PL Dang, ... Europace 26 (Supplement_1), euae102. 691, 2024 | | 2024 |
Clinical courses and costs for hospitalizations of potentially immunocompromised COVID-19 patients in Germany D Häckl, M Pignot, PL Dang, V Lauenroth, F Jah, CM Wendtner Deutsche Medizinische Wochenschrift (1946) 149 (7), e38-e46, 2024 | | 2024 |
Was Ärzte bei Versagen des Pace-Sense Anteils von Defibrillationselektroden tun: Eine Umfrage in Deutschland, Österreich und der Schweiz P Lacour, A Parwani, M Huemer, P Attanasio, PL Dang, J Luebcke, ... Herz 45, 362-368, 2020 | | 2020 |